Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Langabeer · SciRah

Researcher profile · Semantic Scholar

S. Langabeer

Share profile

S. Langabeer — researcher profile on SciRah

h-index: 24
Works: 260
Citations: 3,111

Most-cited papers

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
H. White, Matthew Salmon, F. Albano, C. Andersen +57 more
2022Leukemia36 citations Open access
Semantic Scholar
Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis
S. Langabeer, K. Haslam, J. Kelly, John Quinn +2 more
2018Clinical and Translational Oncology21 citations
Semantic Scholar
Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms
Thomas A. Frawley, C. O'Brien, E. Conneally, E. Vandenberghe +3 more
2018Genetic Testing and Molecular Biomarkers11 citations
Semantic Scholar
Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP
Lasse Kjær, V. Skov, M. K. Larsen, M. H. Kristiansen +5 more
2024Molecular Diagnosis & Therapy10 citations Open access
Semantic Scholar
Molecular response to imatinib in KIT F522C-mutated systemic mastocytosis.
V. Broderick, K. Waghorn, S. Langabeer, M. Jeffers +2 more
2019Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis9 citations
Semantic Scholar
Characterization of a novel variant BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia: Implications for molecular monitoring.
M. Crampe, K. Haslam, J. Kelly, E. Conneally +1 more
2017Hematology/Oncology and Stem Cell Therapy9 citations Open access
Semantic Scholar
Frequency and spectrum of atypical BCR-ABL1 transcripts in chronic myeloid leukemia.
Laura Kearney, M. Crampe, S. Langabeer
2020Experimental oncology7 citations Open access
Semantic Scholar
Reduction in molecular diagnostics of myeloproliferative neoplasms during the COVID-19 pandemic
S. Langabeer
2020Irish Journal of Medical Science6 citations Open access
Semantic Scholar
Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy
L. Shackleton, S. Langabeer, D. O'Brien, S. Mccarron +5 more
2019Case Reports in Hematology6 citations Open access
Semantic Scholar
Molecular diagnostic criteria of myeloproliferative neoplasms
Claire Andrews, E. Conneally, S. Langabeer
2023Expert Review of Molecular Diagnostics5 citations
Semantic Scholar
The eosinophilic variant of chronic myeloid leukemia
S. Langabeer
2021EXCLI Journal : Experimental and Clinical Sciences4 citations
Semantic Scholar
Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm
S. Langabeer
2020EXCLI Journal : Experimental and Clinical Sciences4 citations
Semantic Scholar
Molecular Monitoring in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the Variant e13a3 BCR-ABL1 Fusion
M. Crampe, Laura Kearney, D. O'Brien, C. L. Bacon +2 more
2019Case Reports in Hematology4 citations Open access
Semantic Scholar
The JAK2 V617F mutation in retinal vein or artery occlusion
S. Langabeer
2019EXCLI Journal : Experimental and Clinical Sciences4 citations
Semantic Scholar
An acquired NRAS mutation contributes to neutrophilic progression in a patient with primary myelofibrosis
S. Langabeer, K. Haslam, Emma Groarke, E. Conneally
2018British Journal of Haematology4 citations
Semantic Scholar
Detecting CALR Mutations in Splanchnic Vein Thrombosis: Who and How?
S. Langabeer
2018Journal of Translational Internal Medicine4 citations Open access
Semantic Scholar
Detection of JAK2 Exon 12 Mutations in Suspected Polycythemia Vera by Next-Generation Sequencing.
Lisa Lee-Tokar, Laura Kearney, S. Langabeer
2022Clinical Laboratory3 citations
Semantic Scholar
Prevalence of atypical BCR-ABL1 transcript types in adult Philadelphia chromosome-positive acute lymphoblastic leukemia: implications for measurable residual disease
Úna Bhreathnach, Laura Kearney, S. Langabeer
2021Hematology, Transfusion and Cell Therapy3 citations Open access
Semantic Scholar
Quantification of atypical BCR‐ABL1 fusion transcripts in patients with chronic myeloid leukemia: Which approach for harmonization?
Úna Bhreathnach, S. Langabeer
2021International Journal of Laboratory Hematology3 citations Open access
Semantic Scholar
Protracted Clonal Trajectory of a JAK2 V617F-Positive Myeloproliferative Neoplasm Developing during Long-Term Remission from Acute Myeloid Leukemia
S. Langabeer, K. Haslam, Maria Anne Smyth, J. Quinn +1 more
2018Case Reports in Hematology3 citations Open access
Semantic Scholar
Double-mutant myeloproliferative neoplasms
S. Langabeer
2018Medical Oncology3 citations Open access
Semantic Scholar
The mutant CALR allele burden in essential thrombocythemia at transformation to acute myeloid leukemia.
S. Langabeer, K. Haslam, E. Elhassadi
2017Blood Cells, Molecules & Diseases3 citations
Semantic Scholar
Non-canonical BRAF variants and rearrangements in hairy cell leukemia
S. Langabeer
2024Oncology Research2 citations Open access
Semantic Scholar
Incidence and impact of non-canonical JAK2 p.(Val617Phe) mutations in myeloproliferative neoplasm molecular diagnostics
Danielle Patchell, Clodagh Keohane, Susan O’Shea, S. Langabeer
2024Journal of Clinical Pathology2 citations
Semantic Scholar
Noncanonical CALR variants.
S. Langabeer
2023American Journal of Clinical Pathology2 citations
Semantic Scholar
Monitoring KAT6A-CREBBP measurable residual disease in t(8;16) therapy-related acute myeloid leukemia.
Úna Bhreathnach, D. Doherty, K. Murphy, C. Flynn +1 more
2022Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis2 citations
Semantic Scholar
Polycythemia vera emerging eighteen years after acute myeloid leukemia diagnosis
S. Langabeer, D. W. O'Flynn, M. Cahill
2021Blood Research2 citations Open access
Semantic Scholar
Repeat JAK2 V617F testing in patients with suspected essential thrombocythaemia
Laura Kearney, Lisa Lee-Tokar, C. Flynn, V. Mykytiv +2 more
2020Journal of Clinical Pathology2 citations
Semantic Scholar
Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemias
H. Fogarty, Anita Dowling, D. O'Brien, S. Langabeer +11 more
2020Irish Journal of Medical Science2 citations Open access
Semantic Scholar
The role of a low erythropoietin level in the diagnosis of JAK2 exon 12-mutated polycythemia vera.
S. Langabeer
2020Blood Cells, Molecules & Diseases2 citations
Semantic Scholar
Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia
S. Langabeer, Rehman Faryal, M. O'Dwyer, Sorcha Ní Loingsigh
2020Case Reports in Hematology2 citations Open access
Semantic Scholar
“JAK2 V617F Mutation in Cervical Cancer Related to HPV & STIs” - Letter
S. Langabeer
2019Journal of Cancer Prevention2 citations Open access
Semantic Scholar
Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia.
S. Langabeer, K. Haslam, M. Crampe, B. MacDonagh +1 more
2019Experimental oncology2 citations Open access
Semantic Scholar
The mutational landscape of atypical chronic myeloid leukemia
S. Langabeer
2019EXCLI Journal : Experimental and Clinical Sciences2 citations
Semantic Scholar
Serum ferritin as a biomarker of polycythemia vera?
S. Langabeer
2018EJIFCC2 citations
Semantic Scholar
Reflective molecular testing for myeloproliferative neoplasms in patients with elevated serum vitamin B12
S. Langabeer
2018Annals of Clinical Biochemistry2 citations
Semantic Scholar
An increase in diagnostic JAK2 V617F mutation testing: Is masked polycythaemia vera the explanantion?
S. Langabeer
2018European journal of internal medicine2 citations
Semantic Scholar
The JAK2 V617F mutation in lung cancer: caveat emptor.
S. Langabeer
2018Experimental oncology2 citations
Semantic Scholar
Dual Drivers in the Myeloproliferative Neoplasms: An Underestimation?
S. Langabeer
2023Technology in Cancer Research and Treatment1 citations Open access
Semantic Scholar
A temporal cluster of acute promyelocytic leukemia
S. Langabeer
2023EXCLI Journal : Experimental and Clinical Sciences1 citations
Semantic Scholar
Pyoderma gangrenosum and myeloproliferative neoplasms.
S. Langabeer
2023Clincal and Experimental Dermatology1 citations
Semantic Scholar
Persisting with persistent thrombocytosis
S. Langabeer, A. Burke
2023International Journal of Laboratory Hematology1 citations
Semantic Scholar
Frequency and driver mutation diversity of concomitant chronic myeloid leukemia and Philadelphia chromosome-negative myeloproliferative neoplasm
S. Langabeer, A. Jones, E. Conneally, H. Enright +4 more
2023International journal of hematology1 citations
Semantic Scholar
MPL exon 10 mutations in Irish patients with a suspected myeloproliferative neoplasm
Lisa Lee-Tokar, Laura Kearney, S. Langabeer
2021EXCLI Journal : Experimental and Clinical Sciences1 citations
Semantic Scholar
Molecular responses in e19a2 BCR-ABL1 chronic myeloid leukemia
Laura Kearney, M. Crampe, E. Conneally, J. Krawczyk +5 more
2020Leukemia Research Reports1 citations Open access
Semantic Scholar
Prefibrotic Myelofibrosis Presenting with Multiple Cerebral Embolic Infarcts and the Rare MPL W515S Mutation
S. Langabeer, Lisa Lee-Tokar, Laura Kearney, C. O'Brien +4 more
2020Case Reports in Hematology1 citations Open access
Semantic Scholar
Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?
S. Langabeer, Úna Bhreathnach, M. Cahill, E. Elhassadi +3 more
2020Blood Cells, Molecules & Diseases1 citations
Semantic Scholar
CALR mutations in myeloproliferative neoplasms: An unfolding story
S. Langabeer
2020EXCLI Journal : Experimental and Clinical Sciences1 citations
Semantic Scholar
Screening for an underlying myeloproliferative neoplasm in patients with thrombocytosis post-induction chemotherapy for acute myeloid leukemia
S. Langabeer
2020Leukemia Research Reports1 citations Open access
Semantic Scholar
Molecular screening for an underlying myeloproliferative neoplasm in patients with stroke: who and how?
S. Langabeer
2020Blood Research1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Conneally×8
Invite
E. Conneally — researcher profile on SciRah
Laura Kearney×8
Invite
Laura Kearney — researcher profile on SciRah
K. Haslam×7
Invite
K. Haslam — researcher profile on SciRah
M. Crampe×5
Invite
M. Crampe — researcher profile on SciRah

×4

Invite

Lisa Lee-Tokar — researcher profile on SciRah

Úna Bhreathnach×4

Invite

Úna Bhreathnach — researcher profile on SciRah

Invite

D. O'Brien — researcher profile on SciRah

Invite

C. L. Bacon — researcher profile on SciRah

Invite

C. Flynn — researcher profile on SciRah

Invite

N. Cross — researcher profile on SciRah

Invite

J. Kelly — researcher profile on SciRah

E. Vandenberghe×2

Invite

E. Vandenberghe — researcher profile on SciRah